MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, TARS has $562,158K in assets. $218,732K in debts.

Balance Sheets Overview

Current Ratio
385.26%
Quick Ratio
382.04%
Debt to Asset Ratio
38.91%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Accounts receivable, net
    • Prepaid expenses
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accrued payroll and benefits
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
183,641
Restricted cash
560
Marketable securities
233,627
Accounts receivable, net
85,057
Inventory
4,372
Other receivables
2,052
Prepaid expenses
13,473
Total current assets
522,782
Restricted cash, non-current
2,002
Inventory, non-current
2,532
Property and equipment, net
11,665
Intangible assets, net
7,366
Operating lease right-of-use assets
10,080
Long-term investments
3,870
Other assets
1,861
Total assets
562,158
Accounts payable
16,387
Accrued payroll and benefits
17,779
Other accrued liabilities
101,529
Total current liabilities
135,695
Long-term debt, net
72,438
Other long-term liabilities
10,599
Total liabilities
218,732
Common stock, 0.0001 par value 200,000,000 shares authorized 42,553,931 shares issued and outstanding at december31, 2025 38,349,826 shares issued and outstanding at december31, 2024
6
Additional paid-in capital
769,667
Accumulated other comprehensive income (loss)
381
Accumulated deficit
-426,628
Total stockholders equity
343,426
Total liabilities and stockholders equity
562,158
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$233,627K Cash and cashequivalents$183,641K Accounts receivable, net$85,057K Prepaid expenses$13,473K Inventory$4,372K Other receivables$2,052K Restricted cash$560K Total current assets$522,782K Property and equipment,net$11,665K Operating leaseright-of-use assets$10,080K Intangible assets, net$7,366K Long-term investments$3,870K Inventory, non-current$2,532K Restricted cash,non-current$2,002K Other assets$1,861K Total assets$562,158K Total liabilities andstockholders equity$562,158K Total stockholdersequity$343,426K Total liabilities$218,732K Accumulated deficit-$426,628K Additional paid-in capital$769,667K Total currentliabilities$135,695K Long-term debt, net$72,438K Other long-termliabilities$10,599K Accumulated othercomprehensive income (loss)$381K Common stock, 0.0001par value...$6K Other accruedliabilities$101,529K Accrued payroll andbenefits$17,779K Accounts payable$16,387K

Tarsus Pharmaceuticals, Inc. (TARS)

Tarsus Pharmaceuticals, Inc. (TARS)